These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6114975

  • 1. Studies on immunopathogenesis in epidemic hemorrhagic fever: sequential observations on activation of the first complement component in sera from patients with epidemic hemorrhagic fever.
    Yan D, Gu X, Wang D, Yang S.
    J Immunol; 1981 Sep; 127(3):1064-7. PubMed ID: 6114975
    [Abstract] [Full Text] [Related]

  • 2. Studies on immunopathogenesis in epidemic hemorrhagic fever: role of classical complement pathway activation in pathogenesis.
    Yang SH, Gu XS, Wang DQ, Yan DY.
    Chin Med J (Engl); 1981 Dec; 94(12):789-98. PubMed ID: 6120798
    [No Abstract] [Full Text] [Related]

  • 3. [The role of the classical pathway of complement activation in the pathogenic mechanism of epidemic hemorrhagic fever (author's transl)].
    Wang DQ.
    Zhonghua Nei Ke Za Zhi; 1981 Dec; 20(12):707-10. PubMed ID: 6123415
    [No Abstract] [Full Text] [Related]

  • 4. Activation of the alternative complement pathway in patients with epidemic hemorrhagic fever.
    Gu XS, Wang DQ, Yang SH, Yan DY.
    Chin Med J (Engl); 1984 Apr; 97(4):283-90. PubMed ID: 6148201
    [No Abstract] [Full Text] [Related]

  • 5. The role of tissue immune complex, complement activation and its immunopathologic injury in the pathogenesis of the epidemic hemorrhagic fever.
    Wang JR, Yang PZ, Wu Q, Sun T, Xu ZY, Dai ZY.
    Chin Med J (Engl); 1986 Jan; 99(1):21-6. PubMed ID: 2873969
    [No Abstract] [Full Text] [Related]

  • 6. [Inhibitory effect of selenium on complement activation and its clinical significance].
    Hou JC, Jiang ZY, He ZF.
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):645-6, 699. PubMed ID: 7907268
    [Abstract] [Full Text] [Related]

  • 7. [Complement-mediated solubilization of the immune complex in patients with epidemic hemorrhagic fever].
    Ni CY.
    Zhonghua Yi Xue Za Zhi; 1987 May; 67(5):250-2. PubMed ID: 2888522
    [No Abstract] [Full Text] [Related]

  • 8. [The biggest epidemic of hemorrhagic fever with renal syndrome in Croatia].
    Kuzman I, Puljiz I, Turcinov D, Markotić A, Turković B, Aleraj B, Andrić Z, Petković D, Tutek V, Herendić B, Iskra M, Pandak N, Misetić Z, Perić L, Jelaska D, Majetić-Sekovanić M, Ledina D, Misić-Majerus L, Radonić R.
    Acta Med Croatica; 2003 May; 57(5):337-46. PubMed ID: 15011458
    [Abstract] [Full Text] [Related]

  • 9. [Clinical observation of liver damages in epidemic hemorrhagic fever].
    Tang ZY, Ye XG, Liao YZ, Li SH.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):593-4, 598. PubMed ID: 15897149
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effect of selenite and other antioxidants on complement-mediated tissue injury in patients with epidemic hemorrhagic fever.
    Hou JC.
    Biol Trace Elem Res; 1997 Jan; 56(1):125-30. PubMed ID: 9152516
    [No Abstract] [Full Text] [Related]

  • 11. [Activation of the alternative complement pathway in patients with epidemic hemorrhagic fever].
    Gu XS.
    Zhonghua Nei Ke Za Zhi; 1983 Dec; 22(12):722-5. PubMed ID: 6144469
    [No Abstract] [Full Text] [Related]

  • 12. Early analysis of viremia and clinical tests in patients with epidemic hemorrhagic fever.
    Zhang TM, Yang ZQ, Zhang MY, Hu ZJ, Xiang JM, Huggins JW, Cosgriff TM, Smith JI.
    Chin Med J (Engl); 1993 Aug; 106(8):608-10. PubMed ID: 7900974
    [Abstract] [Full Text] [Related]

  • 13. [Kinetic observation on BRC immune function of patients with epidemic hemorrhagic fever].
    Kang Y, Wang WY, Zhao WQ.
    Zhonghua Nei Ke Za Zhi; 1991 Jun; 30(6):357-9, 383. PubMed ID: 1680614
    [Abstract] [Full Text] [Related]

  • 14. [The kinetic changes in immunological function and pathogenesis of epidemic hemorrhagic fever].
    Xing GG.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Oct; 4(5):288-91. PubMed ID: 6144393
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical and epidemiologic characteristics of hemorrhagic fever with renal syndrome in patients treated at the Dr. Fran Mihaljević Clinic for Infectious Diseases in Zagreb].
    Puljiz I, Kuzman I, Turcinov D, Markotić A, Celjuska E.
    Acta Med Croatica; 2003 Oct; 57(5):347-53. PubMed ID: 15011459
    [Abstract] [Full Text] [Related]

  • 16. Modified low density lipoproteins differentially bind and activate the C1 complex of complement.
    Biró A, Thielens NM, Cervenák L, Prohászka Z, Füst G, Arlaud GJ.
    Mol Immunol; 2007 Feb; 44(6):1169-77. PubMed ID: 16938346
    [Abstract] [Full Text] [Related]

  • 17. [Laboratory findings in patients with hemorrhagic fever with renal syndrome].
    Puljiz I, Kuzman I, Turcinov D, Makek N, Markotić A.
    Acta Med Croatica; 2005 Feb; 59(2):105-11. PubMed ID: 15909883
    [Abstract] [Full Text] [Related]

  • 18. CNS manifestations of epidemic hemorrhagic fever. An advanced manifestation of disease associated with poor prognosis.
    Cohen MS, Kwei HE, Chin CC, Ge HC.
    Arch Intern Med; 1983 Nov; 143(11):2070-2. PubMed ID: 6139098
    [Abstract] [Full Text] [Related]

  • 19. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G, van Es LA, Daha MR.
    Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
    [Abstract] [Full Text] [Related]

  • 20. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP, Burger R, Golan MD, Loos M.
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.